Average Co-Inventor Count = 4.02
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (22 from 1,970 patents)
2. Nanjing Zhengxiang Pharmaceuticals Co., Ltd. (4 from 4 patents)
3. Syntex (u.s.a.) Inc. (2 from 932 patents)
4. Japan Tobacco Inc. (1 from 1,037 patents)
5. Teijin Pharma Limited (1 from 124 patents)
6. Hangzhou Zhengxiang Pharmaceuticals Co., Ltd. (1 from 1 patent)
7. Nanjing Zenshine Pharmaceuticals Co., Ltd. (0 patent)
28 patents:
1. 11673889 - Substituted imidazo[4,5-c][1,8]naphthyridines as phosphodiesterase inhibitors
2. 11542262 - Phosphatidylinositol 3-kinase inhibitors
3. 11466029 - Compounds useful to treat influenza virus infections
4. 11446301 - Quinoline analogs as phosphatidylinositol 3-kinase inhibitors
5. 10792283 - Quinoline analogs as phosphatidylinositol 3-kinase inhibitors
6. 9873704 - Heterocyclic compounds and their uses
7. 9873701 - Heterocyclic compounds and their uses
8. 9365522 - Pyrazole amide derivative
9. 8901135 - Heterocyclic compounds and their uses
10. 8835432 - Heterocyclic compounds and their uses
11. 8754089 - Heterocyclic compounds and their uses
12. 8716290 - Heterocyclic compounds and their uses
13. 8633313 - Heterocyclic compounds and their uses
14. 8586739 - Heterocyclic compounds and their uses
15. 8329910 - Quinolines for the treatment of PI3K-δ mediated diseases